Influence of Dose Intensity in Consolidation with HIDAC and Other Clinical and Biological Parameters in the Survival of AML

Figure 2

Overall survival for AML patients stratified by (a) age groups, (b) leukocyte count, (c) cytogenetic risk, and (d) response groups after induction.

(a)

(b)

(c)

(d)